Major infection during methotrexate treatment for rheumatoid arthritis

Seminars in Arthritis and Rheumatism

Volumn 25, Issue 5, 1996, Pages 357-359

  Schnabel, A ^a   Burchardi, C ^a   Gross, W L ^a   Boerbooms, A M T ^a   Kerstens, P J S M ^a   Van Loephout, J W A ^a   Van de Putte, L ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

METHOTREXATE; METHYLPREDNISOLONE;

CLINICAL FEATURE; COHORT ANALYSIS; DOSE RESPONSE; DRUG EFFICACY; DRUG TOLERANCE; HUMAN; LETTER; MAJOR CLINICAL STUDY; OPPORTUNISTIC INFECTION; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; SKIN INFECTION;

EID: 0029977585     PISSN: 00490172     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-0172(96)80021-7     Document Type: Letter

References (6)

1. Boerbooms A.M.Th. Kerstens P.J.S.M. van Loenhout J.W.A. Infections during low-dose methotrexate treatment in rheumatoid arthritis Semin Arthritis Rheum 24 1995 411 421
2. Schnabel A, Herlyn K, Burchardi Ch, et al. Long-termtolerability of MTX at doses exceeding 15 mg/week in rheumatoid arthritis. Rheumatol Int (in press)
3. Schnabel A. Reinhold-Keller E. Willmann V. Tolerability of methotrexate starting with 15 or 25 mg/week for rheumatoid arthritis Rheumatol Int 14 1994 33 38
4. van der Veen M.J. van der Heide A. Kruize A.A. Infection rate and use of antibiotics in patients with rheumatoid arthritis treated with methotrexate Ann Rheum Dis 53 1994 224 228
5. Singh G. Fries J.F. Williams C.A. Toxicity profiles of disease modifying antirheumatic drugs in rheumatoid arthritis J Rheumatol 18 1991 188 194
6. van Albada-Kuipers G.A. Linthorst J. Peters E.A.J. Frequency of infection among patients with rheumatoid arthritis versus patients with osteoarthritis or soft tissue rheumatism Arthritis Rheum 31 1988 667 671